Bank of Montreal
NYMX

Bank of Montreal’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Bank of Montreal’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,939
Closed -$5K – 5239
2021
Q1 		$5K Sell
1,939
-5,264
-73% -$13.9K ﹤0.01% 4678
2020
Q4 		$19K Buy
7,203
+430
+6% +$950 ﹤0.01% 4447
2020
Q3 		$17K Buy
6,773
+3,233
+91% +$9.41K ﹤0.01% 3911
2020
Q2 		$12K Buy
3,540
+3,210
+973% +$10.2K ﹤0.01% 4100
2020
Q1 		$1K Hold
330
– – ﹤0.01% 4016
2019
Q4 		$1K Hold
330
– – ﹤0.01% 4828
2019
Q3 		$1K Hold
330
– – ﹤0.01% 4689
2019
Q2 		$0 Sell
330
-12,500
-97% -$21.9K ﹤0.01% 5134
2019
Q1 		$26K Sell
12,830
-8,234
-39% -$17.5K ﹤0.01% 3582
2018
Q4 		$27K Buy
21,064
+13,397
+175% +$24.5K ﹤0.01% 3539
2018
Q3 		$19K Sell
7,667
-98,392
-93% -$291K ﹤0.01% 3733
2018
Q2 		$356K Buy
106,059
+37,229
+54% +$143K ﹤0.01% 2497
2018
Q1 		$291K Buy
68,830
+61,500
+839% +$213K ﹤0.01% 2459
2017
Q4 		$24K Buy
7,330
+1,000
+16% +$3.65K ﹤0.01% 3535
2017
Q3 		$24K Sell
6,330
-4,000
-39% -$15.2K ﹤0.01% 3470
2017
Q2 		$45K Buy
10,330
+10,000
+3,030% +$41.1K ﹤0.01% 3266
2017
Q1 		$1K Hold
330
– – ﹤0.01% 3912
2016
Q4 		$1K Sell
330
-13,575
-98% -$42.1K ﹤0.01% 3992
2016
Q3 		$45K Buy
13,905
+13,500
+3,333% +$44.2K ﹤0.01% 3082
2016
Q2 		$1K Hold
405
– – ﹤0.01% 4009
2016
Q1 		$1K Hold
405
– – ﹤0.01% 4111
2015
Q4 		$1K Hold
405
– – ﹤0.01% 4127
2015
Q3 		$1K Hold
405
– – ﹤0.01% 3907
2015
Q2 		$0 Sell
405
-2,670
-87% -$3.73K ﹤0.01% 4160
2015
Q1 		$3K Hold
3,075
– – ﹤0.01% 3729
2014
Q4 		$1K Sell
3,075
-3,850
-56% -$8.21K ﹤0.01% 3943
2014
Q3 		$30K Hold
6,925
– – ﹤0.01% 3325
2014
Q2 		$34K Hold
6,925
– – ﹤0.01% 3373
2014
Q1 		$37K Sell
6,925
-200
-3% -$1.16K ﹤0.01% 3249
2013
Q4 		$43K Hold
7,125
– – ﹤0.01% 2937
2013
Q3 		$47K Buy
7,125
+3,075
+76% +$20.1K ﹤0.01% 2859
2013
Q2 		$21K Buy
+4,050
New +$20.5K ﹤0.01% 3074

Other funds holding NYMX

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TEE
Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
WB
Webster Bank Waterbury, Connecticut $1.15B AUM 23.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

Bank of Montreal's NYMX Position: Q2 2021 in Review

Bank of Montreal sold out of Nymox Pharmaceutical Corp (NYMX) in Q2 2021, closing a stake of 1,939 shares — an estimated $5K sold.

Bank of Montreal first reported a position in NYMX in Q2 2013 and held it in 32 quarters. The position peaked at $356K in Q2 2018. 51 funds tracked by Wall St. Rank hold NYMX as of Q2 2021.

  • Bank of Montreal reported no remaining Nymox Pharmaceutical Corp position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 1,939 Nymox Pharmaceutical Corp shares in Q2 2021, an estimated $5K.
  • Bank of Montreal first reported a position in Nymox Pharmaceutical Corp in Q2 2013 and held it in 32 quarters.
  • Bank of Montreal's Nymox Pharmaceutical Corp position peaked at $356K in Q2 2018.
  • 51 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.